Canonical transient receptor potential channels in diabetes

Experimental Biology and Medicine

Volumn 237, Issue 2, 2012, Pages 111-118

  Graham, Sarabeth ^a   Yuan, Joseph P ^a   Ma, Rong ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Calcium; Diabetes; Diabetic complications; TRPC

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; GLUCOSE; MESSENGER RNA; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL 7; VASCULAR CELL ADHESION MOLECULE 1; CALCIUM; G PROTEIN COUPLED RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 4 ALPHA; ISOPROTEIN; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; TRANSIENT RECEPTOR POTENTIAL CHANNEL C 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL C 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL C 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL C 5; TRANSIENT RECEPTOR POTENTIAL CHANNEL C 6; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL ADHESION; CELL MIGRATION; CEREBROVASCULAR DISEASE; CHROMOSOME 3Q; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; ERECTILE DYSFUNCTION; GENE EXPRESSION; GENE LOCATION; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; KIDNEY PARENCHYMA; MESANGIUM; MESANGIUM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SMOOTH MUSCLE FIBER; STREPTOZOCIN DIABETES; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION; BLOOD VESSEL; CALCIUM HOMEOSTASIS; CARDIOVASCULAR DISEASE; CELL FUNCTION; DOWN REGULATION; INTRACELLULAR SIGNALING; KIDNEY DISEASE;

ANIMALS; ATHEROSCLEROSIS; CALCIUM; CALCIUM SIGNALING; DIABETES COMPLICATIONS; DIABETES MELLITUS; GLUCOSE; HUMANS; MODELS, BIOLOGICAL; PROTEIN ISOFORMS; REACTIVE OXYGEN SPECIES; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRPC CATION CHANNELS;

EID: 84857325488     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011208     Document Type: Review

References (87)

1. Abramowitz J, Birnbaumer L. Physiology and pathophysiology of canonical transient receptor potential channels. FASEB J 2009;23:297-328
2. Clapham DE. TRP channels as cellular sensors. Nature 2003;426:517-24
3. Goel M, Sinkins WG, Zuo CD, Schilling WP. Identification and localization of TRPC channels in rat kidney. Am J Physiol Renal Physiol 2006;290:F1241-52
4. Liu D, Zhu Z, Tepel M. The role of transient receptor potential channels in metabolic syndrome. Hypertens Res 2008;31:1989-95
5. 2+ signaling in glomerular mesangial cells. Am J Physiol Renal Physiol 2007;293:F1381-90
6. Venkatachalam K, Montell C. TRP channels. Annu Rev Biochem 2007;76:387-417
7. Hsu Y, Hoenderop JGJ, Bindels RJM. TRP channels in kidney disease. Biochimica et Biophysica Acta 2007;1772:928-36
8. Dietrich A, Chubanov V, Gudermann T. Renal TRPathies. J Am Soc Nephrol 2010;21:736-44
9. Chung AW, Yeung KA, Chum E, Okon EB, van Breemen C. Diabetes modulates capacitative calcium entry and expression of transient receptor potential canonical channels in human saphenous vein. Eur J Pharmacol 2009;613:114-8
10. Bishara NB, Ding H. Glucose enhances expression of TRPC1 and calcium entry in endothelial cells. Am J Physiol Heart Circ Physiol 2010;298:H171-8
11. Wuensch T, Thilo F, Krueger K, Scholze A, Ristow M, Tepel M. High glucose-induced oxidative stress increases transient receptor potential (TRP) channel expression in human monocytes. Diabetes 2010;59:844-9
12. Zhang D, Freedman BI, Flekac M, Santos E, Hicks PJ, Bowden DW, Efendic S, Brismar K, Gu HF. Evaluation of genetic association and expression reduction of TRPC1 in the development of diabetic nephropathy. Am J Nephrol 2009;29:244-51
13. 2+ influx is mediated by the 1/4/5 subgroup of the transient receptor potential proteins in cultured aortic smooth muscle cells from diabetic Goto-Kakizaki rats. Mol Cell Endocrinol 2009;302:49-57
14. Niehof M, Borlak J. Hepatic nuclear factor 4 alpha and the Ca-channel TRPC1 are novel disease candidate genes in diabetic nephropathy. Diabetes 2008;57:1069-77
15. 2+ entry and enhanced expression of TRPC channels in caudal artery smooth muscle from type 2 diabetic Goto-Kakizaki rats. Clin Exp Pharmacol Physiol 2010;37:670-8
16. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-20
17. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 1998;47:1164-9
18. Freedman BI, Bowden DW, Sale MM, Langefeld CD, Rich SS. Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus. Hypertension 2006;48:8-13
19. McKnight AJ, Maxwell AP, Sawcer S, Compston A, Setakis E, Patterson CC, Brady HR, Savage DA. A genome-wide diabetic nephropathy: a microsatellite association screen to identify chromosomal regions harboring candidate genes in diabetic nephropathy. J Am Soc Nephrol 2006;17:831-6
20. Du J, Sours-Brothers S, Coleman R, Ding M, Graham S, Kong D, Ma R. Canonical transient receptor potential 1 channel is involved in contractile function of glomerular mesangial cells. J Am Soc Nephrol 2007;18:1437-45
21. Sours S, Du J, Chu S, Zhou JX, Ding M, Ma R. Expression of canonical transient receptor potential (TRPC) proteins in human glomerular mesangial cells. Am J Physiol Renal Physiol 2006;290:F1507-15
22. Graham S, Gorin Y, Abboud HE, Ding M, Lee DY, Shi H, Ding Y, Ma R. Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes. Am J Physiol Cell Physiol 2011;301:C304-C315
23. Sours-Brothers S, Ma R. Canonical transient receptor potential (TRPC) channels in renal microcirculation. Microcirculation: Function, Malfunction, and Measurement. Hauppauge, NY, USA: Nova Publishers, 2009:25-38
24. Nutt LK, O'Neil RG. Effect of elevated glucose on endothelin-induced store-operated and non-store-operated calcium influx in renal mesangial cells. J Am Soc Nephrol 2000;11:1225-35
25. Whiteside CI, Hurst RD, Stevanovic ZS. Calcium signaling and contractile response of diabetic glomerular mesangial cells. Kidney Int 1995;48(Suppl 51):S28-33
26. Hada SJ, Ferreira AT, Oshiro MEM, Neri R, Schor N. Alteration of cytosolic calcium induced by angiotensin II and norepinephrine in mesangial cells from diabetic rats. Kidney Int 1997;51:87-93
27. 2+ signaling microdomains: platforms for the assembly and regulation of TRPC channels. TiPS 2006;27:25-32
28. Hofmann T, Schaefer M, Schultz G, Gudermann T. Subunit composition of mammalian transient receptor potential channels in living cells. Proc Natl Acad Sci USA 2002;99:7461-6
29. Chorzempa A. Type 2 diabetes mellitus and its effect on vascular disease. J Cardiovas Nurs 2006;21:485-92
30. Cooper ME, Bonnet F, Oldfield M, Jandeleit-Dahm K. Mechanisms of diabetic vasculopathy: an overview. Am J Hypertens 2001;14:475-86
31. The National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on hypertension in diabetes. Hypertension 1994;23:145-58
32. Bokoch GM, Diebold B, Kim JS, Gianni D. Emerging evidence for the importance of phosphorylation in the regulation of NADPH oxidases. Antioxid Redox Signal 2009;11:2429-41
33. lagaud GJL, Masih-Khan E, Kai S, van Breemen C, Dube GP. Influence of type II diabetes on arterial tone and endothelial function in Murine mesenteeric resistance arteries. J Vasc Res 2001;38:578-89
34. Okon EB, Chung AWY, Rauniyar P, Padilla E, Tejerina T, McManus BM, Luo H, van Breemen C. Compromised arterial function in human type 2 diabetic patients. Diabetes 2005;54:2415-23
35. Jarajapu YPR, Guberski DL, Grant MB, Knot HJ. Myogenic tone and reactivity of cerebral arteries in type II diabetic BBZDR/Wor rat. Eur J Pharmacol 2008;579:298-307
36. 2+ sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells. Am J Physiol Cell Physiol 2010;298:C211-20
37. Yao X, Garland CJ. Recent developments in vascular endothelial cell transient receptor potential channels. Circ Res 2005;97:853-63
38. Beech DJ. Emerging functions of 10 types of TRP cationic channel in vascular smooth muscle. Clin Exp Pharmacol Physiol 2005;32:597-603
39. Pedersen SF, Owsianik G, Nilius B. TRP channels: an overview. Cell Calcium 2005;38:233-52
40. Putney JW. Physiological mechanism of TRPC activation. Pflugers Arch 2005;451:29-34
41. 2+ entry. J Cell Science 2007;120:1959-65
42. 2+ influx. Current Biol 2005;15:1235-41
43. 2+ store to the plasma membrane. Nature 2005;437:902-5
44. Zbidi H, Lopez JJ, Amor NB, Bartegi A, Salido GM, Rosado JA. Enhanced expression of STIM1/Orai1 and TRPC3 in platelets from patients with type 2 diabetes mellitus. Blood Cell Mol Dis 2009;43:211-3
45. Goto Y, Kakizaki M, Masaki N. Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 1976;119:85-90
46. Mita M, Kuramoto T, Ito K, Toguchi-Senrui N, Hishinuma S, Walsh MP, Shoji M. Impairment of x1-adrenoceptor-mediated contractile activity in caudal arterial smooth muscle from type 2 diabetic Goto-kakizaki rats. Clin Exp Pharmacol Physiol 2010;37:350-7
47. Strübing C, Krapivinsky G, Krapivinsky L, Clapham DE. TRPC1 and TRPC5 form a novel cation channel in mammalian brain. Neuron 2001;29:645-55
48. 2+ entry. Cell 1996;85:661-71
49. Andrews KI, Pannirselvam M, Anderson TJ, Jenkins A, Triggle CR, Hill MA. The vascular endothelium in diabetes: a practical target for drug treatment? Expert Opin Ther Targets 2005;9:101-17
50. Vanhoutte PM. Endothelium and control of vascular function. Hypertension 1998;13:658-67
51. Feener EP, King GL. Vascular dysfunction in diabetes mellitus. Lancet 1997;350(Suppl 1):S19-113
52. Clark CM, Lee DA. Prevention and treatment of the complication of diabetes mellitus. N Engl J Med 1995;332:1210-7
53. 2+ regulatory mechanisms of exercise protection against coronary artery disease in metabolic syndrome and diabetes. J Appl Physiol 2011;111:573-86
54. Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature 2008;451:904-13
55. Venkatachalam K, Zheng F, Gill DL. Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C. J Biol Chem 2003;278:29031-40
56. Leung FP, yung LM, Yao X, Laher I, Huang Y. Store-operated calcium entry in vascular smooth muscle. Br J Pharmacol 2007;153:846-57
57. Beech DJ. Ion channel switching and activation in smooth-muscle cells of occlusive vascular diseases. Biochem Soc Trans 2007;35:890-4
58. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-78
59. 2+ entry associated with metabolic syndrome and coronary atherosclerosis. Cardiovas Res 2010;85:631-40
60. Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27:2292-301
61. Smedlund K, Vazquez G. Involvement of native TRPC3 proteins in ATP-dependent expression of VCAM-1 and monocyte adherence in coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 2008;28:2049-55
62. Geissmann F, jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003;19:71-82
63. c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation 2009;119:2708-17
64. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004;141:413-20
65. Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 2001;15:44-54
66. 2+ entry and tyrosine kinase pp 60 (src) hyperactivity are modulated by hyperglycemia in platelets from patients with non-insulin-dependent diabetes mellitus. Arch Biochem Biophys 2004;432:261-8
67. Jardin I, Redondo PC, Salido GM, Rosado JA. Phosphatidylinositol 4,5-bisphosphate enhances store-operated calcium entry through hTRPC6 channel in human platelets. Biochim Biophys Acta 2008;1783:84-97
68. Braum A, Varga-Szabo D, Kleinschnitz C, Pleines I, Bender M, Austinat M, Bosl M, Stoll G, Nieswandt B. Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation. Blood 2009;113:56-63
69. 2+ channels. Cell signal 2009;21:457-61
70. Brownlow SL, Sage SO. Transient receptor potential protein subunit assembly and membrane distribution in human platelets. Thromb Haemost 2005;94:839-45
71. 2+ homeostasis and platelet hyperaggregability in type 2 diabetes mellitus patients. Arch Biochem Biophys 2007;457:235-42
72. Liu D, Maier A, Scholze A, Rauch U, Boltzen U, Zhao Z, Zhu Z, Tepel M. High glucose enhances transient receptor potential channel canonical type 6 (TRPC6)-dependent calcium influx in human platelets via phosphatidylinositol 3-kinase-dependent pathway. Arterioscler Thromb Vasc Biol 2008;28:746-51
73. Bivalacqua TJ, Usta MF, Champion HC, Adams D, McNamara DB, Abdel-Mageed AB, Kadowitz WJG. Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthasis and erectile function in streptozotocin diabetic rats. J Urol 2003;169:1911-7
74. Cellek S, Rodrigo J, Lobos E, Fernández P, Serrano J, Moncada S. Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon. Br J Pharmacol 1999;128:1804-12
75. Rubin A, Babbott D. Impotence and diabetes mellitus. JAMA 1958;168:498-500
76. Jung JH, Kim BJ, Chae MR, Kam SC, Jeon JH, So I, Chung KH, Lee SW. Gene transfer of TRPC6DN (dominant negative) restores erectile function in diabetic rats. J Sex Med 2010;7:1126-38
77. Newton AC. Protein kinase C: structure, function, and regulation. J Biol Chem 1995;270:28495-8
78. 2+ channels in human glomerular mesangial cells. J Biol Chem 2001;276:25759-65
79. 2+ channels in human glomerular mesangial cells. Am J Physiol Cell Physiol 2002;283:C1390-8
80. Whiteside CI, Dlugosz JA. Mesangial cell protein kinase C isozyme activation in the diabetic milieu. Am J Physiol Renal Physiol 2002;282:F975-80
81. Hidalgo C, Donoso P. Crosstalk between calcium and redox signaling: from molecular mechanisms to health implications. Antioxid Redox Signal 2008;10:1275-312
82. Hool LC, Corry B. Redox control of calcium channels: from mechanisms to therapeutic opportunities. Antioxid Redox signal 2007;9:409-35
83. Rhee SG, Chang TS, Bae YS, Lee SR, Kang SW. Cellular regulation by hydrogen peroxide. J Am Soc Nephrol 2003;14:S211-5
84. Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci 2009;84:705-12
85. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med 2008;233:4-11
86. Kim NH, Rincon-Choles H, Bhandari B, Choudhury GG, Abboud HE, Gorin Y. Redox dependence of glomerular epithelial cell hypertrophy in response to glucose. Am J Physiol Renal Physiol 2006;290:F741-51
87. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 2003;14:S241-5